The New Nation - Internet Edition

Staff Reporter

Leaders of Bangladesh Association of Pharmaceuticals Industry (BAPI) at a discussion in the city said there are no substandard ingredients in the Ceftriaxone antibiotic injection.

Ceftriaxone injection is manufactured and controlled by the USP Pharmacopoeia and approved by the Drugs Administration Department. According to the USP, there is no level of impurity in the raw materials or in the finished Ceftriaxone. So there is no harmful chemical used in manufacturing the antibiotic injection. As a result, there is no reason for non-acceptance of the antibiotic injection available in the market, they said.

They protested the news of harmful Ceftriaxone injections marketed by 17 pharmaceutical companies in the country. The discussion on 'Current situation on Pharmaceu-ticals' was organised by BAPI at its office in the city yesterday.

President of BAPI SM Shafiuzzaman, Secretary General Nazmul Hassan, advisers Samson H Chowdhury and Dr Momenul Haq, members of the executive committee Harunur Rashid, Md Halimuzzaman and Syed S Kaisar Kabir, among others, were present at the meeting.

It is mentioned that recently in the market, the price of the injection ranged between Tk 60 and Tk 320 for one gm, 500 mg and 250 mg Ceftriaxone antibiotic injections. The important antibiotic injections were being sold by different pharmaceutical companies at various rates.